The interplay between intracellular progesterone receptor and PKC plays a key role in migration and invasion of human glioblastoma cells

2017 ◽  
Vol 172 ◽  
pp. 198-206 ◽  
Author(s):  
Brenda Marquina-Sánchez ◽  
Jesús González-Jorge ◽  
Valeria Hansberg-Pastor ◽  
Talia Wegman-Ostrosky ◽  
Noemi Baranda-Ávila ◽  
...  
2018 ◽  
Vol 477 ◽  
pp. 81-89 ◽  
Author(s):  
Juan Carlos González-Orozco ◽  
Valeria Hansberg-Pastor ◽  
Paulina Valadez-Cosmes ◽  
Walter Nicolas-Ortega ◽  
Yenifer Bastida-Beristain ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Claudia Bello-Alvarez ◽  
Aylin Del Moral-Morales ◽  
Aliesha González-Arenas ◽  
Ignacio Camacho-Arroyo

Glioblastomas are the most common and aggressive primary brain tumors in adults, and patients with glioblastoma have a median survival of 15 months. Some alternative therapies, such as Src family kinase inhibitors, have failed presumably because other signaling pathways compensate for their effects. In the last ten years, it has been proven that sex hormones such as progesterone (P4) can induce growth, migration, and invasion of glioblastoma cells through its intracellular progesterone receptor (PR), which is mostly known for its role as a transcription factor, but it can also induce non-genomic actions. These non-classic actions are, in part, a consequence of its interaction with cSrc, which plays a significant role in the progression of glioblastomas. We studied the relation between PR and cSrc, and its effects in human glioblastoma cells. Our results showed that P4 and R5020 (specific PR agonist) activated cSrc protein since both progestins increased the p-cSrc (Y416)/cSrc ratio in U251 and U87 human glioblastoma derived cell lines. When siRNA against the PR gene was used, the activation of cSrc by P4 was abolished. The co-immunoprecipitation assay showed that cSrc and PR interact in U251 cells. P4 treatment also promoted the increase in the p-Fak (Y397) (Y576/577)/Fak and the decrease in p-Paxillin (Y118)/Paxillin ratio, which are significant components of the focal adhesion complex and essential for migration and invasion processes. A siRNA against cSrc gene blocked the increase in the p-Fak (Y576/Y577)/Fak ratio and the migration induced by P4, but not the decrease in p-Paxillin (Y118)/Paxillin ratio. We analyzed the potential role of cSrc over PR phosphorylation in three databases, and one putative tyrosine residue in the amino acid 87 of PR was found. Our results showed that P4 induces the activation of cSrc protein through its PR. The latter and cSrc could interact in a bidirectional mode for regulating the activity of proteins involved in migration and invasion of glioblastomas.


2019 ◽  
Vol Volume 13 ◽  
pp. 1023-1032 ◽  
Author(s):  
Jingren Shi ◽  
Wenli Zhang ◽  
Lu He ◽  
Fanhong Kong ◽  
Meichen Pan ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Araceli Gutiérrez-Rodríguez ◽  
Valeria Hansberg-Pastor ◽  
Ignacio Camacho-Arroyo

Progesterone-induced blocking factor (PIBF) is a progesterone (P4) regulated protein expressed in different types of high proliferative cells including astrocytomas, the most frequent and aggressive brain tumors. It has been shown that PIBF increases the number of human astrocytoma cells. In this work, we evaluated PIBF regulation by P4 and the effects of PIBF on proliferation, migration, and invasion of U87 and U251 cells, both derived from human glioblastomas. PIBF mRNA expression was upregulated by P4 (10 nM) from 12 to 24 h. Glioblastoma cells expressed two PIBF isoforms, 90 and 57 kDa. The content of the shorter isoform was increased by P4 at 24 h, while progesterone receptor antagonist RU486 (10 μM) blocked this effect. PIBF (100 ng/mL) increased the number of U87 cells on days 4 and 5 of treatment and induced cell proliferation on day 4. Wound-healing assays showed that PIBF increased the migration of U87 (12–48 h) and U251 (24 and 48 h) cells. Transwell invasion assays showed that PIBF augmented the number of invasive cells in both cell lines at 24 h. These data suggest that PIBF promotes proliferation, migration, and invasion of human glioblastoma cells.


2009 ◽  
Vol 109 (1) ◽  
pp. 203-213 ◽  
Author(s):  
Hua Guo ◽  
Feng Gu ◽  
Wenliang Li ◽  
Baogang Zhang ◽  
Ruifang Niu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document